A double-blind study of alprazolam and lorazepam in the treatment of anxiety
Ruiz, A.T.
Journal of Clinical Psychiatry 44(2): 60-62
1983
ISSN/ISBN: 0160-6689 PMID: 6131066 Document Number: 4926
In a 4-week double-blind study of 53 psychoneurotic outpatients, alprazolam and lorazepam appeared to be equally safe and effective in relieving anxiety symptoms. The only statistically significant differences between the two treatment groups were in autonomic symptoms at week 1 and in dizziness at week 4. In both cases, the scores favored patients taking alprazolam. Drowsiness and lightheadedness were the most frequent side effects.
Document emailed within 1 workday
